Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer

Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer
ShareXFacebook

(MedPage Today) -- SAN DIEGO -- Investigational zoldonrasib was well tolerated and showed encouraging clinical activity in previously treated KRAS G12D-mutated non-small cell lung cancer (NSCLC), according to a phase I study. Among patients...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement